How can emerging disease-modifying therapies reshape the trajectory of type 1 diabetes?

In this episode, our host, Dr. Alice Cheng, discusses the cutting-edge landscape of type 1 diabetes (T1D) prevention and intervention with Dr. Bruce Perkins, endocrinologist, epidemiologist, clinician-scientist, and professor in the Faculty of Medicine and the Institute for Health Policy, Management and Evaluation at the University of Toronto.

Join our experts as they explore how T1D care is shifting from symptom management through insulin replacement toward early intervention in a disease that develops silently over years. Discover the clinical benefits of early disease modification and the transformative potential of novel therapeutic targets in delaying T ...